Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

Gregory J. Dore,Frederick L. Altice,Alain H. Litwin,Olav Dalgard,Edward Gane,Oren Shibolet,Anne F. Luetkemeyer,Ronald Nahass,Cheng Yuan Peng,Brian Conway,Jason Grebely,Anita Y. M. Howe,I.N. Gendrano,Erluo Chen,Hsueh-Cheng Huang,Frank J. Dutko,David C. Nickle,Bach-Yen Nguyen,Janice Wahl,Eliav Barr,Michael N. Robertson,Heather L. Platt

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

2016

Hepatitis C virus (HCV) infection is common in persons who inject drugs (PWID), a population that generally has been excluded from trials of HCV treatment. This study randomly assigned treatment-na...

Keywords:

Substance abuse
Hepatitis A
Hepatitis C virus
Internal medicine
Cirrhosis
Viremia
Pharmacotherapy
Population
Medicine
Cardiology
Elbasvir, Grazoprevir

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations